Cargando…

Preprocedural C-Reactive Protein Predicts Outcomes after Primary Percutaneous Coronary Intervention in Patients with ST-elevation Myocardial Infarction a systematic meta-analysis

Risk assessment in patients with acute coronary syndromes (ACS) is critical in order to provide adequate treatment. We performed a systematic meta-analysis to assess the predictive role of serum C-reactive protein (CRP) in patients with ST-segment elevation myocardial infarction (STEMI), treated wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mincu, Raluca-Ileana, Jánosi, Rolf Alexander, Vinereanu, Dragos, Rassaf, Tienush, Totzeck, Matthias
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5270244/ https://www.ncbi.nlm.nih.gov/pubmed/28128312 http://dx.doi.org/10.1038/srep41530

Ejemplares similares

Cardiovascular Adverse Events in Patients With Cancer Treated With Bevacizumab: A Meta‐Analysis of More Than 20 000 Patients
por: Totzeck, Matthias, et al.
Publicado: (2017)

Red blood cell transfusion in patients with ST-elevation myocardial infarction—a meta-analysis of more than 21,000 patients
por: Mincu, R. I., et al.
Publicado: (2018)

Novel anticoagulants versus vitamin K antagonists for cardioversion of non- valvular atrial fibrillation – a meta-analysis of more than 17000 patients
por: Mincu, Raluca Ileana, et al.
Publicado: (2019)

Global longitudinal strain is associated with better outcomes in transcatheter aortic valve replacement
por: Al-Rashid, Fadi, et al.
Publicado: (2020)

Heart failure from cancer therapy: can we prevent it?
por: Totzeck, Matthias, et al.
Publicado: (2019)

Access site complications following Impella-supported high-risk percutaneous coronary interventions
por: Johannsen, Laura, et al.
Publicado: (2019)

Impact of left-ventricular end-diastolic pressure as a predictor of periprocedural hemodynamic deterioration in patients undergoing Impella supported high-risk percutaneous coronary interventions
por: Al-Rashid, Fadi, et al.
Publicado: (2019)

Impact of Cancer in Patients Undergoing Transcatheter Aortic Valve Replacement: A Single-Center Study
por: Lind, Alexander, et al.
Publicado: (2020)

Left Ventricular Diastolic Function Following Anthracycline-Based Chemotherapy in Patients with Breast Cancer without Previous Cardiac Disease—A Meta-Analysis
por: Mincu, Raluca I., et al.
Publicado: (2021)

Frequency and prognosis of CVD and myocardial injury in patients presenting with suspected COVID-19 – The CoV-COR registry
por: Mahabadi, Amir A., et al.
Publicado: (2023)

Cardiac biomarkers for the detection of cardiotoxicity in childhood cancer—a meta‐analysis
por: Michel, Lars, et al.
Publicado: (2020)

Cardiovascular Adverse Events Associated With BRAF and MEK Inhibitors: A Systematic Review and Meta-analysis
por: Mincu, Raluca I., et al.
Publicado: (2019)

Embolic Protection with the TriGuard 3 System in Nonagenarian Patients Undergoing Transcatheter Aortic Valve Replacement for Severe Aortic Stenosis
por: Lind, Alexander, et al.
Publicado: (2022)

Percutaneous coronary intervention in the elderly with ST-segment elevation myocardial infarction
por: Gao, Lei, et al.
Publicado: (2014)

Primary percutaneous coronary intervention for ST elevation myocardial infarction in nonagenarians
por: Petroni, Thibaut, et al.
Publicado: (2016)

ECG Changes in Melanoma Patients Undergoing Cancer Therapy—Data from the ECoR Registry
por: Pohl, Julia, et al.
Publicado: (2020)

Troponins and Natriuretic Peptides in Cardio-Oncology Patients—Data From the ECoR Registry
por: Hinrichs, Lena, et al.
Publicado: (2020)

PD1 Deficiency Modifies Cardiac Immunity during Baseline Conditions and in Reperfused Acute Myocardial Infarction
por: Michel, Lars, et al.
Publicado: (2022)

The Transaxillary Approach via Prosthetic Conduit for Transcatheter Aortic Valve Replacement With the New-Generation Balloon-Expandable Valves in Patients With Severe Peripheral Artery Disease
por: Lind, Alexander, et al.
Publicado: (2022)

No reflow phenomenon in percutaneous coronary interventions in ST-segment elevation myocardial infarction
por: Gupta, Sanjiv, et al.
Publicado: (2016)

Impact of Diabetes Mellitus on Outcomes after High-Risk Interventional Coronary Procedures
por: Johannsen, Laura, et al.
Publicado: (2020)

Use of extracorporeal membrane oxygenation as a bridge to transcatheter aortic valve replacement in a patient with aortic stenosis and severe coronary artery disease: a case report
por: Ahsan, Majid, et al.
Publicado: (2021)

Epicardial adipose tissue is a robust measure of increased risk of myocardial infarction – a meta-analysis on over 6600 patients and rationale for the EPIC-ACS study
por: Hendricks, Stefanie, et al.
Publicado: (2021)

Preprocedural Ticagrelor Treatment was Associated with Improved Early Reperfusion and Reduced Short-term Heart Failure in East-Asian ST-segment Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention
por: Zhang, Yunke, et al.
Publicado: (2021)

Disconcordance between ESC prevention guidelines and observed lipid profiles in patients with known coronary artery disease()
por: Dykun, Iryna, et al.
Publicado: (2018)

Crosstalk between Nitrite, Myoglobin and Reactive Oxygen Species to Regulate Vasodilation under Hypoxia
por: Totzeck, Matthias, et al.
Publicado: (2014)

Prognosis of primary percutaneous coronary intervention in elderly patients with ST-elevation myocardial infarction
por: Alkhushail, Abdullah, et al.
Publicado: (2015)

Distal Protection During Primary Percutaneous Coronary Intervention for ST-elevation Myocardial Infarction
por: Ishihara, Masaharu
Publicado: (2016)

Benefit of primary percutaneous coronary interventions in the elderly with ST segment elevation myocardial infarction
por: Fernández-Bergés, Daniel, et al.
Publicado: (2020)

ECG Scoring for the Evaluation of Therapy-Naïve Cancer Patients to Predict Cardiotoxicity
por: Pohl, Julia, et al.
Publicado: (2021)

The Elevated Soluble ST2 Predicts No-Reflow Phenomenon in ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
por: Somuncu, Mustafa Umut, et al.
Publicado: (2019)

Percutaneous left atrial appendage closure for stroke prevention in patients with chronic renal disease
por: Lind, Alexander, et al.
Publicado: (2020)

Influence of the Timing of Percutaneous Coronary Intervention on Clinical Outcomes in Non-ST-Elevation Myocardial Infarction
por: Tekin, Kamuran, et al.
Publicado: (2013)

A comparison of rescue and primary percutaneous coronary interventions for acute ST elevation myocardial infarction
por: Faslur Rahuman, M.B., et al.
Publicado: (2017)

Predictors and outcome of no-reflow post primary percutaneous coronary intervention for ST elevation myocardial infarction
por: Mazhar, Jawad, et al.
Publicado: (2015)

Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction Before and During COVID in New York
por: Hannan, Edward L., et al.
Publicado: (2021)

Population Density Analysis of Percutaneous Coronary Intervention for ST‐Segment–Elevation Myocardial Infarction in Japan
por: Yamaji, Kyohei, et al.
Publicado: (2020)

Association of thrombocytopenia and infection in patients with ST-elevation myocardial infarction undergoing percutaneous coronary intervention
por: Wang, Litao, et al.
Publicado: (2021)

Prolonged mechanical ventilation after left ventricular assist device implantation: risk factors and clinical implications
por: Papathanasiou, Maria, et al.
Publicado: (2019)

A practical approach to remote ischemic preconditioning and ischemic preconditioning against myocardial ischemia/reperfusion injury
por: Totzeck, Matthias, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_hjetkn9p853t148pq3nll3ehnl